Publications by authors named "Melvin Johnson"

rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination.

View Article and Find Full Text PDF

Objective: In November 2015, a 15-year-old boy received a diagnosis of Ebola virus disease (EVD) at the John F. Kennedy Medical Center in Monrovia, Liberia. Two additional family members received a diagnosis of EVD.

View Article and Find Full Text PDF

Introduction: This article describes a retrospective review of participant follow-up and retention strategies in the Partnership for Research on the Ebola Virus in Liberia (PREVAIL) I Vaccine Trial. It illustrates and analyzes strategies used to retain participants in an emergency clinical research response vaccine trial conducted during the 2014 Ebola outbreak in Liberia.

Methods: An anecdotal review of participant retention strategies developed and employed during the PREVAIL I vaccine trial.

View Article and Find Full Text PDF

Background: The safety and efficacy of vaccines to prevent Ebola virus disease (EVD) were unknown when the incidence of EVD was peaking in Liberia.

Methods: We initiated a randomized, placebo-controlled, phase 3 trial of the chimpanzee adenovirus 3 vaccine (ChAd3-EBO-Z) and the recombinant vesicular stomatitis virus vaccine (rVSV∆G-ZEBOV-GP) in Liberia. A phase 2 subtrial was embedded to evaluate safety and immunogenicity.

View Article and Find Full Text PDF

Clinical trials are challenging endeavors. Planning and implementing an investigational vaccine trial in Liberia, in the midst of an Ebola virus disease (EVD) epidemic that World Health Organization classified a public health emergency of international concern, presented extraordinary challenges. Normally, years of preparation and a litany of tasks lay the groundwork for a successful, randomized, blinded, placebo-controlled trial focused on safety and efficacy.

View Article and Find Full Text PDF

The index case of the Ebola virus disease epidemic in West Africa is believed to have originated in Guinea. By June 2014, Guinea, Liberia, and Sierra Leone were in the midst of a full-blown and complex global health emergency. The devastating effects of this Ebola epidemic in West Africa put the global health response in acute focus for urgent international interventions.

View Article and Find Full Text PDF

Unlabelled: Recently, the U.S. Environmental Protection Agency (EPA) posted a ground-based optical remote sensing method on its Web site called Other Test Method (OTM) 10 for measuring fugitive gas emission flux from area sources such as closed landfills.

View Article and Find Full Text PDF

This study evaluated the impact of gas concentration and wind sensor locations on the accuracy of measuring gas emission rates from a lagoon environment using the backward Lagrangian stochastic (bLS) inverse-dispersion technique. Path-integrated concentrations (PICs) and three-dimensional (3D) wind vector data were collected at different locations within the lagoon landscape. A floating 45 m × 45 m perforated pipe network on an irrigation pond was used as a synthetic distributed emission source for the controlled release of methane.

View Article and Find Full Text PDF

Oxygen transfer efficiencies of various components of the marsh-pond-marsh (M-P-M) and marsh-floating bed-marsh (M-FB-M) wetlands treating swine wastewater were determined by performing oxygen mass balance around the wetlands. Biological oxygen demand (BOD) and total nitrogen (TN) loading and escaping rates from each wetland were used to calculate carbonaceous and nitrogenous oxygen demands. Ammonia emissions were measured using a wind tunnel.

View Article and Find Full Text PDF

Improved characterization of distributed emission sources of greenhouse gases such as methane from concentrated animal feeding operations require more accurate methods. One promising method is recently used by the USEPA. It employs a vertical radial plume mapping (VRPM) algorithm using optical remote sensing techniques.

View Article and Find Full Text PDF

Background: Apolipoprotein A5 (ApoA5) originally gained attention as a regulator of serum triglyceride concentrations through transgenic mouse studies. Our group recently developed the first assay to quantify serum ApoA5 protein concentrations and demonstrated that they are increased by administration of a potent peroxisome proliferator-activated receptor-alpha agonist.

Methods: To better characterize the circulating ApoA5, the protein was purified from human serum, and a definitive N-terminal protein sequence was obtained.

View Article and Find Full Text PDF